|
2021
|
Invention
|
Thiazolide compounds for treating viral infections.
Thiazolide compounds, such as nitazoxanide a... |
|
|
Invention
|
Use of thiazolides against coronaviruses.
Disclosed is use of thiazolides, such as nitazoxanide ... |
|
|
Invention
|
Use of thiazolides against coronaviruses. Disclosed is use of thiazolides, such as nitazoxanide a... |
|
|
Invention
|
Use of thiazolides against coronaviruses. CoronaviridaeOrthocoronavirinaeOrthocoronavirinae subfa... |
|
|
Invention
|
Crystalline salts of tizoxanide and 2-hydroxy-n-(5-chloro-1,3-thiazol-2-yl)benzamide (rm-4848) wi... |
|
|
Invention
|
Compounds and methods for treating influenza. This invention is directed to methods for treating ... |
|
2020
|
Invention
|
Antiviral combinations of thiazolide compounds. The present disclosure relates to treatment of he... |
|
2019
|
Invention
|
Screening for anti-hepatitis b compounds. A screening system may include a) an HBx protein fused ... |
|
|
Invention
|
Controlled release pharmaceutical formulations of nitazoxanide. Solid dosage formulations of nita... |
|
|
Invention
|
Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseas... |
|
|
Invention
|
Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof. P... |
|
2018
|
Invention
|
Inhibition of protein disulfide-isomerase a3. Provided are methods of treating a disease or condi... |
|
|
Invention
|
Haloalkyl heteroaryl benzamide compounds. A new class of haloalkyl heteroaryl benzamides is descr... |
|
2017
|
Invention
|
Controlled release pharmaceutical formulations of nitozoxanide. Solid dosage formulations of nita... |
|
|
Invention
|
Viral hepatitis treatment. The present disclosure relates to methods for treating viral hepatitis... |
|
|
Invention
|
Thiazolide compounds for treating viral infections. Thiazolide compounds, such as nitazoxanide an... |
|
|
Invention
|
Thiazolide compounds for treating viral infections. ABSTRACT Thiazolide compounds, such as nitazo... |
|
2016
|
G/S
|
Pharmaceuticals, namely, anti-infectives.
Pharmaceutical preparation for the treatment of influen... |
|
|
G/S
|
Pharmaceutical preparation for the treatment of influenza or
other respiratory infection; pharma... |
|
|
G/S
|
Pharmaceutical preparation for the treatment of influenza or other respiratory infection.; Pharma... |
|
2015
|
G/S
|
Pharmaceutical preparation for the treatment of influenza and other respiratory infection. |
|
|
G/S
|
Pharmaceutical preparation for the treatment of influenza or other respiratory infection. |
|
|
G/S
|
Pharmaceutical preparation for the treatment of influenza or
other respiratory infection. |
|
2014
|
G/S
|
Pharmaceutical preparation for the treatment of influenza or other respiratory infection |
|
2012
|
Invention
|
Alkylsulfonyl-substituted thiazolide compounds. A new class of alkylsulfonyl-substituted thiazoli... |
|
2011
|
Invention
|
Pharmaceutical compositions and methods of use of salicylanilides for treatment of hepatitis viru... |
|
|
Invention
|
Alkylsulfinyl-substituted thiazolide compounds. A new class of alkylsulfinyl thiazolides is descr... |
|
2010
|
Invention
|
Haloalkyl heteroaryl benzamide compounds. The disclosure relates to haloalkyl heteroaryl benzamid... |
|
2003
|
G/S
|
Produits pharmaceutiques, à savoir produits anti infectieux. |
|
2002
|
G/S
|
Pharmaceuticals, namely, anti infective |
